Snowflake Score | |
---|---|
Valuation | 6/6 |
Future Growth | 3/6 |
Past Performance | 3/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | Ft9,299.08 |
52 Week High | Ft9,826.60 |
52 Week Low | Ft7,278.73 |
Beta | 0.41 |
1 Month Change | -4.42% |
3 Month Change | 6.12% |
1 Year Change | 24.44% |
3 Year Change | 2.13% |
5 Year Change | 71.73% |
Change since IPO | 148.64% |
Recent News & Updates
Recent updates
Shareholder Returns
0QFP | GB Pharmaceuticals | GB Market | |
---|---|---|---|
7D | -0.3% | 4.8% | 2.3% |
1Y | 24.4% | 2.5% | 2.7% |
Return vs Industry: 0QFP exceeded the UK Pharmaceuticals industry which returned 0.6% over the past year.
Return vs Market: 0QFP exceeded the UK Market which returned 3.7% over the past year.
Price Volatility
0QFP volatility | |
---|---|
0QFP Average Weekly Movement | 3.1% |
Pharmaceuticals Industry Average Movement | 9.5% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.3% |
10% least volatile stocks in GB Market | 2.5% |
Stable Share Price: 0QFP has not had significant price volatility in the past 3 months.
Volatility Over Time: 0QFP's weekly volatility has decreased from 11% to 3% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1901 | 12,167 | Gabor Orban | https://www.richter.hu |
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. researches, develops, manufactures, markets, and sells pharmaceutical products worldwide. The company operates through two segments, Pharmaceuticals, and Wholesale and Retail.
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. Fundamentals Summary
0QFP fundamental statistics | |
---|---|
Market cap | Ft1.69t |
Earnings (TTM) | Ft158.85b |
Revenue (TTM) | Ft805.16b |
10.7x
P/E Ratio2.1x
P/S RatioIs 0QFP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0QFP income statement (TTM) | |
---|---|
Revenue | Ft805.16b |
Cost of Revenue | Ft283.83b |
Gross Profit | Ft521.32b |
Other Expenses | Ft362.47b |
Earnings | Ft158.85b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 26, 2024
Earnings per share (EPS) | 869.11 |
Gross Margin | 64.75% |
Net Profit Margin | 19.73% |
Debt/Equity Ratio | 6.0% |
How did 0QFP perform over the long term?
See historical performance and comparison